Literature DB >> 16756636

Macrophage accumulation in human progressive diabetic nephropathy.

Duy Nguyen1, Fu Ping, Wei Mu, Prudence Hill, Robert C Atkins, Steven J Chadban.   

Abstract

BACKGROUND: Diabetic nephropathy is a major global health problem. Progression to renal failure is common; however, the mechanisms are unknown. Experimental models suggest a role for macrophages. Therefore, macrophage accumulation and its relationship to the subsequent clinical course were studied.
METHODS: A retrospective study of baseline histology and the subsequent clinical course over at least 5 years involving 20 consecutive patients with a histological and clinical diagnosis of diabetic nephropathy was performed. The relationship between macrophage accumulation in renal biopsy tissue (KP-1/anti-CD68+ cells), baseline measures of known predictors of progression (proteinuria, tubulointerstitial damage, myofibroblast accumulation) and progression over 5 years (plot of reciprocal of serum creatinine) was quantified.
RESULTS: Accumulation of macrophages was apparent in the glomeruli (2.8 + 0.7/gcs vs 1.0 + 0.2 for normals, P = not significant) and interstitium (296.9 + 63.3/mm(2) vs 19.0 + 1.3/mm(2) for normals, P = 0.002) of patients with diabetic nephropathy. Glomerular macrophage number correlated with baseline serum creatinine (r = 0.548, P = 0.012) but not with progression of renal failure as glomerular macrophages were prevalent in early, but not advanced diabetic nephropathy. Interstitial macrophage accumulation correlated strongly with serum creatinine (r = 0.649, P = 0.002), proteinuria (r = 0.779, P < 0.0001), interstitial fibrosis (r = 0.774, P < 0.0001) and inversely with the slope of 1/serum creatinine (r = -0.531, P = 0.023).
CONCLUSION: Macrophages accumulate within glomeruli and the interstitium in diabetic nephropathy and the intensity of the interstitial infiltrate is proportional to the rate of subsequent decline in renal function. These human data support animal studies that suggest a pathogenic role for the macrophage in diabetic nephropathy.

Entities:  

Mesh:

Year:  2006        PMID: 16756636     DOI: 10.1111/j.1440-1797.2006.00576.x

Source DB:  PubMed          Journal:  Nephrology (Carlton)        ISSN: 1320-5358            Impact factor:   2.506


  92 in total

1.  1,25-Dihydroxyvitamin D₃ suppresses inflammation-induced expression of plasminogen activator inhibitor-1 by blocking nuclear factor-κB activation.

Authors:  Yunzi Chen; Juan Kong; Tao Sun; George Li; Frances L Szeto; Weicheng Liu; Dilip K Deb; Youli Wang; Qun Zhao; Ravi Thadhani; Yan Chun Li
Journal:  Arch Biochem Biophys       Date:  2010-12-19       Impact factor: 4.013

2.  Deletion of soluble epoxide hydrolase gene improves renal endothelial function and reduces renal inflammation and injury in streptozotocin-induced type 1 diabetes.

Authors:  Ahmed A Elmarakby; Jessica Faulkner; Mohammed Al-Shabrawey; Mong-Heng Wang; Krishna Rao Maddipati; John D Imig
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-08-10       Impact factor: 3.619

3.  Cathepsin S-Dependent Protease-Activated Receptor-2 Activation: A New Mechanism of Endothelial Dysfunction.

Authors:  David J Nikolic-Paterson
Journal:  J Am Soc Nephrol       Date:  2015-11-20       Impact factor: 10.121

Review 4.  Pathophysiology of diabetic kidney disease: impact of SGLT2 inhibitors.

Authors:  Ralph A DeFronzo; W Brian Reeves; Alaa S Awad
Journal:  Nat Rev Nephrol       Date:  2021-02-05       Impact factor: 28.314

5.  Monocyte/macrophage chemokine receptor CCR2 mediates diabetic renal injury.

Authors:  Alaa S Awad; Gilbert R Kinsey; Konstantine Khutsishvili; Ting Gao; W Kline Bolton; Mark D Okusa
Journal:  Am J Physiol Renal Physiol       Date:  2011-08-31

6.  Macrophages directly mediate diabetic renal injury.

Authors:  Hanning You; Ting Gao; Timothy K Cooper; W Brian Reeves; Alaa S Awad
Journal:  Am J Physiol Renal Physiol       Date:  2013-10-30

7.  MicroRNA-155 Mediates Obesity-Induced Renal Inflammation and Dysfunction.

Authors:  Chenfei Zheng; Ji Zhang; Xinxin Chen; Jianna Zhang; Xiaokai Ding; Xiaohan You; Lin Fan; Chaosheng Chen; Ying Zhou
Journal:  Inflammation       Date:  2019-06       Impact factor: 4.092

Review 8.  Emerging roles of hematopoietic cells in the pathobiology of diabetic complications.

Authors:  Hideto Kojima; Jongoh Kim; Lawrence Chan
Journal:  Trends Endocrinol Metab       Date:  2014-02-04       Impact factor: 12.015

9.  Prospective associations of circulating adipocyte fatty acid-binding protein levels with risks of renal outcomes and mortality in type 2 diabetes.

Authors:  Chi Ho Lee; Chloe Y Y Cheung; Yu Cho Woo; David T W Lui; Michele M A Yuen; Carol H Y Fong; Wing Sun Chow; Amin Xu; Karen S L Lam
Journal:  Diabetologia       Date:  2018-09-28       Impact factor: 10.122

10.  Requirement for TLR2 in the development of albuminuria, inflammation and fibrosis in experimental diabetic nephropathy.

Authors:  Jin Ma; Huiling Wu; Cathy Y Zhao; Usha Panchapakesan; Carol Pollock; Steven J Chadban
Journal:  Int J Clin Exp Pathol       Date:  2014-01-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.